Skip to main content
. 2020 May 12;24(11):6324–6339. doi: 10.1111/jcmm.15274

Figure 6.

Figure 6

miR‐210‐3p promotes a pro‐metastatic phenotype by targeting FGFRL1. A, TargetScan, miRTarBase and miDB software analyses of potential targets of miR‐210‐3p. B, qPCR analysis of BDNF, E2F3, FGFRL1, KCMF1 and NDUFA4. Control vs. miR‐210‐3p mimic or miR‐NC, respectively. C, Sequence alignment of the binding sites on the 3’UTR of miR‐210‐3p and FGFRL1. D, Luciferase activity in A549 and NCI‐H1703 cells after transfection. miR‐NC vs. miR‐210‐3p mimic. E, Western blot analysis of FGFRL1. *P < .05. **P < .01. Data are mean ± SD from three independent experiments performed in triplicate